Home › Funds › Qube Research & Technologies Ltd › NTRA

Qube Research & Technologies Ltd position in NTRA

NATERA INC · Health Care

Qube Research & Technologies Ltd reported holding 649,288 shares of NTRA (NATERA INC) in its Q3 2026 13F filing — a position valued at US$268.4M, representing 0.53% of its reported portfolio and ranking #11 among its reported holdings. Qube Research & Technologies Ltd has disclosed NTRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)649.29K sh
Reported value held$268.36M
Portfolio Weight0.53%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Qube Research & Technologies Ltd's NTRA position evolved

Qube Research & Technologies Ltd first disclosed a stake in NTRA in Q3 2023 at 45,585 shares (US$2.0M). The position peaked in Q3 2026 at 649,288 shares, worth US$268.4M. Across 13 filings, Qube Research & Technologies Ltd increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 649,288 shares valued at US$268.4M — an increase of 488,209 shares quarter over quarter.. Notable position changes include a 597% increase in Q1 2024 (shares rose 18% over the following quarter), a 378% increase in Q2 2024 (shares rose 18% over the following quarter), a 303% increase in Q3 2026 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 45.59K $2.02M New
Q4 2023 13.11K $821.27K Reduce
Q1 2024 91.44K $8.36M Add
Q2 2024 436.99K $47.32M Add
Q3 2024 327.63K $41.59M Reduce
Q4 2024 740.37K $117.20M Add
Q1 2025 495.21K $70.03M Reduce
Q2 2025 206.47K $34.88M Reduce
Q3 2025 351.70K $56.61M Add
Q4 2025 367.86K $84.27M Add
Q1 2026 306.30K $61.26M Reduce
Q2 2026 161.08K $43.72M Reduce
Q3 2026 649.29K $268.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NTRA and 13F data

NTRA (NATERA INC) is a Health Care company. 54 other funds we track also report a position in NTRA — the largest reported positions include Fidelity Management & Research (FMR) (US$5.65B), Duquesne Family Office LLC (US$864.9M), Castle Hook Partners LP (US$704.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NTRA

All NTRA fund holders →

FAQ

How long has Qube Research & Technologies Ltd held NTRA?

Qube Research & Technologies Ltd has disclosed NTRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Qube Research & Technologies Ltd's current position in NTRA?

As of Q3 2026, Qube Research & Technologies Ltd holds 649.29K shares of NTRA (NATERA INC), valued at $268.36M, representing 0.53% of its reported portfolio and ranking #11.

Has Qube Research & Technologies Ltd been buying or selling NTRA?

In the latest 13F filing (Q3 2026), Qube Research & Technologies Ltd increased its position in NTRA. The position peaked in Q3 2026 at 649.29K shares.

Which other funds hold NTRA?

Other major institutional holders of NTRA include Fidelity Management & Research (FMR), Duquesne Family Office LLC, Castle Hook Partners LP, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.